Colony assays were performed for 50 patients with B cell precursor acute lymphoblastic leukemia (ALL). Blast colony formation was observed for 33 patients, and the plating efficiency (PE) showed a marked interpatient variation, which indicates a pronounced biological heterogeneity at the level of leukemic progenitor cells. Notably, the mean PE of leukemic B cell precursors from patients with a pseudodiploid or near-diploid karyotype with structural chromosomal abnormalities (SCA) was significantly higher than the mean PE of normal diploid or hyperdiploid cases. All patients who had SCA involving 7p13, 11q23-24, or 12pll-13, and patients with a Philadelphia chromosome had high PE values. The S phase percentage, expression of CD19 antigen, and relapse status were also correlated with PE. Significantly, colony blasts had slightly different surface marker profiles in each case and were common ALL antigen negative in 33% of cases, which indicates the existence of a marked immunological heterogeneity at the level of leukemic progenitor cells.
Introduction
Leukemic progenitor cells have been implicated in maintenance-expansion of leukemic cell populations, and, therefore, analysis of the biological diversity of this clonogenic self-renewing subpopulation is of paramount importance. The current paucity of knowledge regarding acute lymphoblastic leukemia (ALL)' progenitor cells largely reflects the historic diffiPresented in part at the 28th Annual Meeting of the American Society of Hematology, San Francisco, December, 1986, and as abstracts (1986. Blood. 68:155) (1986. Blood. 68:268) . This is publication No. 30 from the Center for Experimental Transplantation and Cancer Re- search.
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1. Abbreviations used in this paper: ALL, acute lymphoblastic leukemia; CQ, cytoplasmic u; CALLA, common ALL antigen; DI, DNA index; FAB, French-American-British; FITC, fluorescein isothiocyaculties in cloning fresh ALL blasts in vitro (1) (2) (3) (4) (5) (6) (7) (8) . In recent years, considerable effort has been invested in developing novel cell culture techniques to reveal information about the biological characteristics of leukemic progenitor cells in ALL (1) (2) (3) (4) (5) (6) (7) (8) . These techniques may provide greater understanding of the basic biology of ALL and insight into pathogenesis.
Recently, we have developed a colony assay system that enables us to culture leukemic progenitor cells in B cell precursor ALL (6) . The purposes of the present analysis were (a) to elucidate the proliferative and immunophenotypic characteristics of 50 patients with B cell precursor ALL at the level of leukemic progenitor cells, and (b) to determine whether the in vitro growth characteristics of ALL blasts correlate with more commonly measured disease-and host-related parameters. To our knowledge, this report is the first detailed comparative analysis of the in vitro proliferative activity of leukemic B lineage lymphoid progenitor cells. We provide evidence for (a) a significant relationship between high plating efficiency (PE) of leukemic B lineage lymphoid progenitor cells, structural chromosomal abnormalities (SCA), and high S phase percentage, and (b) a marked biological and immunological heterogeneity at the level of leukemic progenitor cells in B cell precursor ALL.
Methods
Patient materiaL 50 patients with B cell precursor ALL were included in this study. Bone marrow aspirate samples were procured by routine procedures. Morphological classification was performed on WrightGiemsa stained slides according to a modification of the original French-American-British (FAB) nomenclature (9) . Diagnosis was based upon the morphological, cytochemical, and surface marker profiles of marrow blasts.
Surface marker analyses. Marrow blasts were isolated by a single centrifugation of aspirate samples on Ficoll-Hypaque (1.077 g/cm3).
Immunological marker analyses by indirect immunofluorescence and flow cytometry were performed, as previously described (6) Flow microfluorometric DNA analysis. DNA content and cell cycle distribution of leukemic marrow blasts were evaluated by flow cytometric DNA analysis as previously described (14) (15) (16) (17) . In brief, density gradient-separated fresh marrow blasts were washed twice in phosphate-buffered saline, fixed with 96% ethanol, resuspended in 0.5 ml of a 0.5% pepsin solution (3,000 U/mg, Serva, Heidelberg, FRG) in 0.9% NaCl containing 0.25% HCi, incubated 5 min at room temperature on a laboratory shaker, and flushed 100 times through a thin-tipped Pasteur pipette for dispersal. The cell suspensions were adjusted to 1 X 105 cells/ml in a freshly prepared DNA-specific fluorochrome solution that consisted of 0.5 Mig/ml 4',6-diamidino-2-phenylindol and 20 Mg/ml ribonuclease (from bovine pancreas, 100 Kunitz U/mg, Serva) in 0. I M tris buffer at pH 7.6. After staining for 30 min, the nuclear fluorescence was measured with a pulse cytophotometer (ICP 22; Phywe A. G., Gottingen, FRG) using the 365 nm ultraviolet light of a mercury high pressure lamp for excitation and a 590 nm barrier filter for measurement of the emitted red light pulses as described (15) . After reaching 10,000 counts in the peak channel, measurements were stopped, and the data, which were stored in a multichannel and analyzer (MCA 8100; Canberra Industries, Meriden, CT), were transferred to the magnetic tape of a graphic computer system (GS 4051 combined with a digital plotter 4662; Tektronix, Inc., Beaverton, OR) for further evaluation. The data for the original pulse-height distributions were processed by means of a computer program that has been described in detail (14) . Standards of identically stained, ethanol-fixed human normal bone marrow mononuclear cells (n = 5) as well as normal peripheral blood mononuclear cells (n = 6) were used for calibration of the 2c-peak channel number. We also used a mixture of stained normal bone marrow mononuclear cells and leukemic marrow cells as a reference standard to identify the modal fluorescence of GO/G, phase leukemic blasts relative to that of GO/G, phase normal cells. A leukemia stem line with a DNA index (DI) (the ratio of the channel numbers of the leukemic and normal GO/G, cells) of 1.00 was determined to be present if the percentage of diploid GO/G, cells was > 20% more than the percentage of "nonblast" cells in Wright-Giemsa stained differential counts. The coefficient ofvariation (CV) ofthe GO/G, phase modal channel numbers (i.e., fluorescence distribution of GO/G, cells) was determined using the formula CV = (HM X 100)/(N X 2.35), where HM was the width of the Go/GI peak at half-maximum height and N was the modal channel number of the GO/G, peak.
Colony assay and analysis ofcolony blasts. B cell precursor ALL blasts from all 50 patients were assayed for in vitro colony formation using a novel model system that has recently been described (6 (6) . Cultured blasts differed morphologically from the bulk of the preculture patients' marrow blasts in that the former had a bigger size, more prominent vacuolation, more prominent nucleoli, and a more irregular nuclear membrane. Colony blasts were periodic acid-Schiff-positive, but Sudan Black-, myeloperoxidase-, and nonspecific esterase-negative. In 10 cases with sufficient day 7 colony blasts (unique patient numbers [UPN] 3, 7, 13, 19, 22-24, 32, 34, and 39), 10,000 cells from pooled day 7 colonies were replated to measure the self-renewal ability of blast progenitors. The surface marker profiles were analyzed on cytospin slides, as previously described (6), using a broad panel of murine mAb that defines lymphoid and myeloid-erythroid differentiation antigens. Specifically, we used the mAb 35.
, and RIO (anti-glycophorin A). FITC-conjugated goat F(ab')2 anti-mouse IgG (Cappel Laboratories) was used as a second antibody. For background fluorescence, an IgG2a murine myeloma protein (UPC 10; Litton Bionetics, Inc.) was substituted for mAb. Furthermore, terminal deoxynucleotidyl transferase (TdT) activity of colony blasts was determined in the last 14 patients by indirect immunofluorescence on methanol-fixed cytospin preparations using immunadsorbent-purified anti-rabbit TdT serum (20 Mg/ml) and FITC-conjugated goat F(ab')2 anti-rabbit IgG (60 Mug/ml). Cell slg was tested by direct fluorescence with FITC-conjugated goat anti-human total Ig (Kallestad Laboratories, Inc.). Cells were evaluated for cytoplasmic M (CM) chains using FHTC-conjugated F(ab')2 goat anti-human IgM heavy chain-specific anti-M (Tago Inc., Burlingame, CA). The percentage of cells expressing each marker was determined using a fluorescent microscope (Carl Zeiss, Inc., Thornwood, NY) equipped with Ploem epi illumination. Quantitative data were obtained from examination of 100-200 cells. Banded chromosome analyses were performed on colony blasts using a modification of our standard procedure (13) . In brief, 1 X 106 blasts from pooled colonies were cultured in flat-bottom tissue-culture plates for 17 h at 37°C in a humidified 5% CO2 atmosphere in the presence of l0-' M amethopterin. Subsequently, thymidine (10-5M) and adenosine (10 Mg/mi) were added and cells were incubated for 4 h. Cells were then subjected to colcemid, transferred to siliconized centrifuge tubes, centrifuged, and resuspended in a prewarmed, hypotonic KC1 solution (1 1.5 g KCI, 0.1 g EDTA, 2.4 g Hepes in 500 ml H20, pH 7.4, 37°C).
After a 55-min incubation at 37°C, cells were fixed using a 3:1 methanol/acetic acid solution, and slides were prepared by conventional techniques. G banding was performed with Wright's stain. 20 to 50 metaphases were completely analyzed, and 5 to 10 cells were karyotyped.
Statistical analysis. We used standard statistical methods, including two-sample t tests, chi-square, one-way analysis of variance, and multiple regression analysis to evaluate the data.
Results
Clinical and diagnostic features. 50 patients with B cell precursor ALL were studied. Patient data are summarized in Using flow microfluorometric DNA analysis, we determined the cellular DNA content distributions of 4',6-diamidino-2-phenylindol-stained leukemic blasts in freshly obtained marrow samples from 31 of 50 patients (Table II) (Table II) . The S phase fraction of blasts in leukemic marrow samples varied widely between patients with a median value of 4.8% (Table II) . By (15) (16) (17) . Banding was unsuccessful only in UPN 1, 20, and 26. t Although all three metaphases were hyperdiploid, each had a different karyotype. DI and % S were determined by DNA-flow cytometry as described (10, 11). Leukemic B cell precursors were cultured in vitro for 7 d and assayed for colony formation as previously described (6) . Data are shown as average number of blast colonies (number of blast colonies in individual replicate dishes) and % PE. (UPN 3, 13, 22, 23, 32, 34, and 39) . Notably, cultured blasts from each case had slightly different marker profiles. These findings suggest the existence of at least two immunologically distinct (CALLA-and CALLA+) leukemic progenitor cell populations in CALLA+ B cell precursor ALL. This hypothesis is further supported by our initial cytogenetic studies on leukemic B cell precursor colony blasts. Primary colony blasts from UPN 38 were not only CALLA-, but they also had a completely different karyotype from the malignant clone detected in the fresh marrow sample that contained 88% CALLA+ blasts.
Associations between in vitro colony formation and other laboratory and clinical parameters. As shown in Table IV , a very pronounced association was established between PE and the karyotypic findings. The mean PE values of fresh marrow blasts from patients with a normal diploid (n = 2) and hyperdiploid (n = 1 1) clone were 0.09 and 0.35%, respectively. Among these 23 cases, only UPN 5, 42, and 45 had PE values higher than the median PE. Significantly, all three patients were hyperdiploid with additional SCA. Bone marrow blasts from 5 of 11 patients (45%) with a hyperdiploid karyotype and from 5 of 12 patients (42%) with a normal diploid karyotype failed to proliferate and form colonies. By comparison, marrow blasts from all patients with a pseudodiploid or hypodiploid karyotype and additional SCA formed blast colonies with a mean PE value of 1.21%. This value is significantly different from the PE values of marrow blasts from normal diploid and hyperdiploid cases (P < 0.001). The PE values for 9 of 11 patients (82%) in this group were higher than the median PE (i.e., 0.408%). When we compared the mean PE values for all patients with and without, SCA we again found a very significant difference (1.04% vs. 0.10%, P < 0.001). Particularly, note that only patients with SCA had a PE higher than the median value of0.408%. Notably, the in vitro growth patterns of marrow blasts from patients with similar cytogenetic abnormalities were consistent; two patients with aberrations involving 7 p13 (UPN 3 and 39) (19, 20, 26 From the surface marker analyses ofcolony blasts in the 33 patients with successful cultures, a marked interpatient variation became apparent in the expression of B lineage surface determinants, not only on the bulk of marrow blasts, but also on the clonogenic subpopulations. Colony cells from each successfully cultured B cell precursor ALL case had slightly different marker profiles. In 33% of cases, cultured blasts did not express detectable amounts ofCALLA, although the initial blast populations were strongly positive for this determinant. Replating experiments were performed to test the self-renewal ability of day 7 colony blasts and the stability oftheir immunophenotype. Secondary colonies were obtained in patients with both CALLA' and CALLA-primary colonies. The secondary PE values ofCALLA' and CALLA-colony blasts were comparable. Since the bulk of initial marrow blasts in all patients were CALLA', and the described culture conditions did not appear to provide a selective growth advantage for CALLA-blasts, the presented data indicate the existence of CALLA-leukemic progenitor cells in a number of patients with CALLA' B cell precursor ALL. Our hypothesis is supported by the clinical observation that the dominant leukemic immunophenotype may change in an individual B cell precursor ALL patient (31, 32) . In one series of 143 patients with B lineage ALL, 19 showed an altered phenotype at relapse, and the most common change was either the loss or acquisition of CALLA (31) . Our findings also agree with Toew et al., who sorted and successfully cultured CALLA' as well as CALLAblast fractions in two patients with B cell precursor ALL (5) .
In summary, we have used a colony assay system to detail the in vitro growth characteristics of fresh marrow blasts and the immunophenotypic features of cultured marrow blasts from 50 B cell precursor ALL patients. Our study exemplifies how this leukemic progenitory cell assay can be used to illuminate the heterogeneity among B cell precursor ALL patients with different clinical-laboratory findings. To our knowledge, this report represents the first detailed comparative analysis of the proliferative activity of clonogenic fresh marrow blasts from B cell precursor ALL patients. Our data provide unique and direct evidence for (a) a marked heterogeneity at the level of leukemic progenitor cells in B cell precursor ALL and (b) a significant correlation between the in vitro proliferative activity of leukemic B cell precursors and certain structural chromosomal abnormalities. Future studies will be necessary to evaluate the prognostic value of in vitro colony formation as a new biological parameter.
